BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Regorafenib
1
Efficacy of regorafenib in the treatment of advanced hepatocellular carcinoma: A systematic review and meta-analysis
1/12/2026 10:07:38 AM | Browse: 12 | Download: 42
2
Efficacy comparison of fruquintinib, regorafenib monotherapy or plus programmed death-1 inhibitors for microsatellite stable metastatic colorectal cancer
6/15/2024 2:49:02 AM | Browse: 111 | Download: 468
3
Second-line therapy for advanced hepatocellular carcinoma with regorafenib or cabozantinib: Multicenter French clinical experience in real-life after matching
8/10/2022 1:14:37 PM | Browse: 536 | Download: 1817
4
Regorafenib combined with programmed cell death-1 inhibitor against refractory colorectal cancer and the platelet-to-lymphocyte ratio’s prediction on effectiveness
4/15/2022 9:40:09 AM | Browse: 595 | Download: 1682
5
Targeted agents for second-line treatment of advanced hepatocellular carcinoma
10/16/2019 12:17:24 PM | Browse: 884 | Download: 1444
6
Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma
8/7/2019 7:09:17 AM | Browse: 1167 | Download: 1982
7
Targeted therapy or immunotherapy? Optimal treatment in hepatocellular carcinoma
5/15/2018 7:28:22 AM | Browse: 1361 | Download: 1829
8
Role of targeted therapy in metastatic colorectal cancer
9/12/2016 10:43:00 AM | Browse: 1253 | Download: 2190
9
Last line therapy with sorafenib in colorectal cancer: A retrospective analysis
6/13/2016 9:14:00 AM | Browse: 1386 | Download: 2728
10
New active drugs for the treatment of advanced colorectal cancer
12/24/2015 8:55:00 AM | Browse: 1103 | Download: 2022
11
Chemotherapy and target therapy for hepatocellular carcinoma: New advances and challenges
4/19/2015 5:46:00 PM | Browse: 1339 | Download: 2024
12
Advances and new perspectives in the treatment of metastatic colon cancer
8/26/2014 4:37:00 PM | Browse: 1408 | Download: 1764
Write to the Help Desk
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345